SE433221B - 2alfa-cyano-3-oxo-androstan-derivat - Google Patents

2alfa-cyano-3-oxo-androstan-derivat

Info

Publication number
SE433221B
SE433221B SE7813067A SE7813067A SE433221B SE 433221 B SE433221 B SE 433221B SE 7813067 A SE7813067 A SE 7813067A SE 7813067 A SE7813067 A SE 7813067A SE 433221 B SE433221 B SE 433221B
Authority
SE
Sweden
Prior art keywords
methyl
hydroxy
compound
represents hydrogen
formula
Prior art date
Application number
SE7813067A
Other languages
English (en)
Swedish (sv)
Other versions
SE7813067L (sv
Inventor
R G Christiansen
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of SE7813067L publication Critical patent/SE7813067L/xx
Publication of SE433221B publication Critical patent/SE433221B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0048—Alkynyl derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0057—Nitrogen and oxygen
    • C07J71/0063—Nitrogen and oxygen at position 2(3)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SE7813067A 1977-12-20 1978-12-19 2alfa-cyano-3-oxo-androstan-derivat SE433221B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/862,417 US4160027A (en) 1977-12-20 1977-12-20 Steroid cyanoketones and intermediates

Publications (2)

Publication Number Publication Date
SE7813067L SE7813067L (sv) 1979-06-21
SE433221B true SE433221B (sv) 1984-05-14

Family

ID=25338450

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7813067A SE433221B (sv) 1977-12-20 1978-12-19 2alfa-cyano-3-oxo-androstan-derivat

Country Status (27)

Country Link
US (1) US4160027A (cs)
JP (2) JPS5488253A (cs)
AR (1) AR222645A1 (cs)
AT (1) AT367070B (cs)
AU (1) AU518997B2 (cs)
BE (1) BE872886A (cs)
CA (1) CA1121340A (cs)
CH (1) CH637409A5 (cs)
DE (1) DE2855091A1 (cs)
DK (1) DK156727C (cs)
ES (1) ES476117A1 (cs)
FI (1) FI66010C (cs)
FR (1) FR2412569A1 (cs)
GB (2) GB2010278B (cs)
HK (1) HK89287A (cs)
IE (1) IE48076B1 (cs)
IL (1) IL56076A (cs)
IT (1) IT1195258B (cs)
LU (1) LU80673A1 (cs)
MX (1) MX5535E (cs)
NL (1) NL190848C (cs)
NO (1) NO151467C (cs)
NZ (1) NZ189035A (cs)
PH (2) PH14778A (cs)
PT (1) PT68926A (cs)
SE (1) SE433221B (cs)
ZA (1) ZA786746B (cs)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4349474A (en) * 1981-07-27 1982-09-14 G. D. Searle & Co. 2-Cyanosteroids
JPS5995300A (ja) * 1982-11-02 1984-06-01 スタ−リング・ドラッグ・インコ−ポレ−テッド コントロ−ルされた粒度の２−シアノ−４，５−エポキシ−３−オキソ−ステロイド類およびそれらの組成物
DK23984A (da) * 1983-02-11 1984-08-12 Hoffmann La Roche D-homosteroider
US4459235A (en) * 1983-03-03 1984-07-10 G. D. Searle & Co. 2-Cyanosteroids
GB8328929D0 (en) * 1983-10-29 1983-11-30 Sterwin Ag Steroid compounds
GB8404980D0 (en) * 1984-02-25 1984-03-28 Sterwin Ag Steroid compound
DE3531903A1 (de) * 1985-09-05 1987-03-12 Schering Ag Oxytocin und antigestagen zur einleitung der geburt bzw. zum therapeutischen abbruch der graviditaet
US4755595A (en) * 1985-11-01 1988-07-05 Sterling Drug Inc. Enhanced production of 4,5-unsaturated steroids utilizing methanol solvation
US4870068A (en) * 1986-05-22 1989-09-26 Sterling Drug Inc. Method of regulating fertility in swine using epostane
US4833133A (en) * 1986-05-22 1989-05-23 Sterling Drug Inc. Method of regulating fertility in cattle using epostane
US5795881A (en) * 1987-06-16 1998-08-18 Schering Aktiengesellschaft Combined use of an antigestagen and a progesterone synthesis inhibitor of the trilostane and epostane type
US5215978A (en) * 1989-06-16 1993-06-01 The Upjohn Company Method of enhancing egg laying in turkeys using epostane
JPH0538929A (ja) * 1991-08-02 1993-02-19 Mitsubishi Heavy Ind Ltd 車両用空気調和装置
GB2375958B (en) * 2001-04-09 2005-03-02 George Margetts The use of steroids to lower the levels of cortisol
GB2414238B (en) * 2004-05-22 2006-12-13 Stegram Pharmaceuticals Ltd Method for the preparation of trilostane
CN101282646B (zh) * 2005-07-12 2013-03-27 Dmi生物科学公司 治疗疾病的方法和产品
PT2554174E (pt) * 2009-06-22 2015-12-15 Ampio Pharmaceuticals Inc Método para o tratamento de doenças
AU2010264525B2 (en) * 2009-06-22 2015-04-02 Ampio Pharmaceuticals, Inc. Methods and products for treatment of diseases
EA201500752A1 (ru) 2012-12-19 2016-05-31 Ампио Фармасьютикалс, Инк. Способ лечения заболеваний

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3296255A (en) * 1963-11-29 1967-01-03 Sterling Drug Inc 2-cyano steroids
US3980638A (en) * 1974-09-20 1976-09-14 The Upjohn Company Testosterone derivatives
US4062954A (en) * 1976-12-27 1977-12-13 Sterling Drug Inc. Process for using a steroid compound

Also Published As

Publication number Publication date
PT68926A (en) 1979-01-01
AT367070B (de) 1982-05-25
GB2010278A (en) 1979-06-27
GB2088878B (en) 1983-01-19
IT1195258B (it) 1988-10-12
IE48076B1 (en) 1984-09-19
IL56076A (en) 1983-06-15
CH637409A5 (fr) 1983-07-29
FI783901A (fi) 1979-06-21
PH16835A (en) 1984-03-15
JPS6361314B2 (cs) 1988-11-28
AU518997B2 (en) 1981-10-29
NO784281L (no) 1979-06-21
DE2855091A1 (de) 1979-06-28
JPS6220998B2 (cs) 1987-05-11
NO151467B (no) 1985-01-02
DK156727C (da) 1990-03-12
ATA888578A (de) 1981-10-15
FI66010B (fi) 1984-04-30
DK156727B (da) 1989-09-25
FI66010C (fi) 1984-08-10
ES476117A1 (es) 1979-11-16
IL56076A0 (en) 1979-01-31
AR222645A1 (es) 1981-06-15
AU4208978A (en) 1979-06-28
BE872886A (fr) 1979-06-20
HK89287A (en) 1987-12-11
DE2855091C2 (cs) 1988-12-22
JPS62142198A (ja) 1987-06-25
SE7813067L (sv) 1979-06-21
FR2412569A1 (fr) 1979-07-20
FR2412569B1 (cs) 1982-05-28
ZA786746B (en) 1979-11-28
JPS5488253A (en) 1979-07-13
GB2088878A (en) 1982-06-16
GB2010278B (en) 1982-10-20
IT7831011A0 (it) 1978-12-19
NZ189035A (en) 1980-08-26
NL190848B (nl) 1994-04-18
PH14778A (en) 1981-12-09
NO151467C (no) 1985-04-17
IE782492L (en) 1979-06-20
LU80673A1 (fr) 1979-07-20
NL7812309A (nl) 1979-06-22
DK569678A (da) 1979-06-21
US4160027A (en) 1979-07-03
NL190848C (nl) 1994-09-16
CA1121340A (en) 1982-04-06
MX5535E (es) 1983-09-27

Similar Documents

Publication Publication Date Title
SE433221B (sv) 2alfa-cyano-3-oxo-androstan-derivat
JP4611019B2 (ja) 代謝異常治療のための新規な糖質コルチコイド受容体結合体
TW201006474A (en) Natural products including an anti-flammatory pharmacore and methods of use
US4545938A (en) Chemical synthesis
DK168444B1 (da) 7beta-methyl- eller 7beta-ethyl-11-aminophenylsteroidforbindelser, fremgangsmåde til fremstilling deraf samt farmaceutiske præparater indeholdende disse
DK168294B1 (da) 6-alkyl-11-aminophenyløstran- og 6-alkyl-11-aminophenyl-19-norpregnanderivater, fremgangsmåde til fremstilling heraf samt farmaceutiske midler indeholdende disse
PL179460B1 (pl) sposób ich wytwarzania oraz srodki lecznicze zawierajace te zwiazki PL PL PL PL PL PL PL PL
US3318926A (en) 7alpha-methyl-16alpha-hydroxy-estrones
US3696091A (en) Novel cardiac-active principles of the cardenolide glycoside class
US4331663A (en) 4α,5α-Epoxy-3,20-dioxopregnane-2α,16α-dicarbonitrile and intermediates and process for preparation, method of use and compositions thereof
EP0116329A1 (de) Neue D-Homosteroide, deren Herstellung und pharmazeutische Präparate
US3422097A (en) 6,6-ethylene spirolactones
DE2855091C3 (cs)
KR820000059B1 (ko) 2α-시아노-3-옥소스테로이드 유도체의 제조방법
US6218425B1 (en) 8-substituted B-nor-6-Thiaequilenin compounds having activity as selective estrogen receptor modulators
US3522281A (en) Delta**3,5-7alpha-methyloestradienes
US20040235810A1 (en) Novel glucocorticoid receptor ligands for the treatment of metabolic disorders
US3388139A (en) 3-enol ethers of progesterone and 6-methyl derivatives thereof
US3565918A (en) 7alpha-difluoromethyl-a-nor-b-homo steroids and their preparation
US3840568A (en) Estratriene derivatives
US3478019A (en) Halogenated cyclopropyl,cyclopropenyl and oxocyclopropenyl-1-hydroxy estratrienes and derivatives thereof
US3506651A (en) Epoxysteroids
US3462465A (en) 6,7-methylene steroids
US3595856A (en) 17beta-hydroxy-20,21-pregnanedicarboxylic acid gamma-lactones and derivatives
US3420820A (en) Unsaturated lactones of the steroid series and process for preparing them

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7813067-1

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7813067-1

Format of ref document f/p: F